BRIEF-Zevra Therapeutics Announces Organizational Changes

Reuters12-07

BRIEF-<a href="https://laohu8.com/S/ZVRA">Zevra Therapeutics</a> Announces Organizational Changes

Dec 6 (Reuters) - Zevra Therapeutics Inc ZVRA.O:

ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGES
ZEVRA THERAPEUTICS INC - CONSOLIDATES DEVELOPMENT AND SCIENTIFIC FUNCTIONS UNDER CMO ADRIAN QUARTEL
ZEVRA THERAPEUTICS INC - ELIMINATES POSITIONS IN CHEMISTRY, MANUFACTURING AND CONTROLS AND CLINICAL DEVELOPMENT
ZEVRA THERAPEUTICS INC - TO CLOSE LABORATORY FACILITIES IN IOWA AND VIRGINIA
ZEVRA THERAPEUTICS INC - ZEVRA HAS DISCONTINUED ITS IN-HOUSE DRUG DISCOVERY ACTIVITIES
ZEVRA THERAPEUTICS INC - CHRISTAL M.M. MICKLE, CHIEF DEVELOPMENT OFFICER, AND SVEN GUENTHER, PH.D., CHIEF SCIENTIFIC OFFICER, TO DEPART CO

Source text: ID:nGNX9N7qYZ

Further company coverage: ZVRA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2489260970?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-07 06:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489260970","market":"us","top_or_hot":-1,"title":"BRIEF-Zevra Therapeutics Announces Organizational Changes","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ZVRA\">Zevra Therapeutics</a> Announces Organizational Changes</title></head><body><p><span>Dec 6 (Reuters)</span><span> - </span>Zevra <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>ZVRA.O</span>:</p><ul><li><p>ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGES</p></li><li><p>ZEVRA THERAPEUTICS INC - CONSOLIDATES DEVELOPMENT AND SCIENTIFIC FUNCTIONS UNDER CMO ADRIAN QUARTEL</p></li><li><p>ZEVRA THERAPEUTICS INC - ELIMINATES POSITIONS IN CHEMISTRY, MANUFACTURING AND CONTROLS AND CLINICAL DEVELOPMENT</p></li><li><p>ZEVRA THERAPEUTICS INC - TO CLOSE LABORATORY FACILITIES IN IOWA AND VIRGINIA</p></li><li><p>ZEVRA THERAPEUTICS INC - ZEVRA HAS DISCONTINUED ITS IN-HOUSE DRUG DISCOVERY ACTIVITIES</p></li><li><p>ZEVRA THERAPEUTICS INC - CHRISTAL M.M. MICKLE, CHIEF DEVELOPMENT OFFICER, AND SVEN GUENTHER, PH.D., CHIEF SCIENTIFIC OFFICER, TO DEPART CO</p></li></ul><p>Source text: <span>ID:nGNX9N7qYZ</span></p><p>Further company coverage: <span>ZVRA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Zevra Therapeutics Announces Organizational Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Zevra Therapeutics Announces Organizational Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-07 06:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUA2DFGMJ:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Zevra Therapeutics Announces Organizational ChangesDec 6 (Reuters) - Zevra Therapeutics Inc ZVRA.O:ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGESZEVRA THERAPEUTICS INC - CONSOLIDATES ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUA2DFGMJ:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZVRA","symbol_name":"Zevra Therapeutics","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUA2DFGMJ:1","article_id":"2489260970","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489260970","pubTimestamp":1733525690,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Zevra Therapeutics Announces Organizational ChangesDec 6 (Reuters) - Zevra Therapeutics Inc ZVRA.O:ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGESZEVRA THERAPEUTICS INC - CONSOLIDATES DEVELO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZVRA":"Zevra Therapeutics","BK4007":"制药"},"translate_title":"简介-Zevra Therapeutics宣布组织变革","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZVRA":0.9},"content_text":"BRIEF-Zevra Therapeutics Announces Organizational ChangesDec 6 (Reuters) - Zevra Therapeutics Inc ZVRA.O:ZEVRA THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGESZEVRA THERAPEUTICS INC - CONSOLIDATES DEVELOPMENT AND SCIENTIFIC FUNCTIONS UNDER CMO ADRIAN QUARTELZEVRA THERAPEUTICS INC - ELIMINATES POSITIONS IN CHEMISTRY, MANUFACTURING AND CONTROLS AND CLINICAL DEVELOPMENTZEVRA THERAPEUTICS INC - TO CLOSE LABORATORY FACILITIES IN IOWA AND VIRGINIAZEVRA THERAPEUTICS INC - ZEVRA HAS DISCONTINUED ITS IN-HOUSE DRUG DISCOVERY ACTIVITIESZEVRA THERAPEUTICS INC - CHRISTAL M.M. MICKLE, CHIEF DEVELOPMENT OFFICER, AND SVEN GUENTHER, PH.D., CHIEF SCIENTIFIC OFFICER, TO DEPART COSource text: ID:nGNX9N7qYZFurther company coverage: ZVRA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2489260970"}